Can enzyme supplements improve symptoms in a patient with low disaccharidase activity and mild reactive hypoglycemia?

Yes, enzyme supplements can help patients with low disaccharidase activity and should be considered as a primary treatment option.

For patients with documented disaccharidase deficiency, enzyme replacement therapy has been shown to be effective, with up to 80% of patients reporting symptomatic benefit 1, 2. The evidence strongly supports using enzyme supplements in your clinical scenario.

Treatment Approach for Disaccharidase Deficiency

Primary Intervention: Enzyme Replacement

• Disaccharidase deficiency is a treatable condition that should be routinely evaluated in adults presenting with gas, bloating, and abdominal symptoms 1
• Recent evidence (2025) demonstrates that disaccharidase deficiency is common in adults with chronic GI symptoms, affecting approximately 40% of symptomatic patients 1
• Enzyme replacement therapy combined with dietary restriction has proven effective for managing these deficiencies 2

Key Clinical Considerations

Enzyme supplementation works by:

• Replacing deficient brush border enzymes (lactase, sucrase, maltase, palatinase, glucoamylase)
• Facilitating proper carbohydrate digestion and absorption
• Reducing malabsorption-related symptoms

Important caveat: The 2025 study found that symptom severity did not directly correlate with the number of enzyme deficiencies 1. Even patients with pan-disaccharidase deficiency (deficient in 3+ enzymes) did not necessarily have worse symptoms than those with single enzyme deficiency, though they did report more weight loss.

Addressing the Reactive Hypoglycemia Component

For the mild reactive hypoglycemia aspect of your patient's presentation, acarbose (an alpha-glucosidase inhibitor) is the evidence-based pharmacologic treatment 3, 4:

• Acarbose reduces postprandial glucose spikes and subsequent insulin surges that trigger reactive hypoglycemia
• Long-term treatment (3+ months) significantly reduces hypoglycemic episodes from 4 times weekly to once weekly 3
• All patients in controlled studies became asymptomatic on regular diets after 4 weeks of acarbose therapy 4
• The mechanism involves slowing carbohydrate absorption, preventing the early hyperglycemic stimulus to excessive insulin secretion

Treatment Algorithm

1. Confirm diagnosis via duodenal biopsy (gold standard) or breath testing for disaccharidase deficiency
2. Initiate enzyme replacement therapy with meals containing the problematic carbohydrates
3. Add acarbose if reactive hypoglycemia persists despite enzyme supplementation
4. Implement dietary modifications alongside enzyme therapy for optimal results
5. Monitor response over 4-8 weeks; adjust enzyme dosing as needed

Common Pitfalls to Avoid

• Don't assume IBS diagnosis without testing for disaccharidase deficiency - patients who fail low FODMAP diets may have undiagnosed enzyme deficiencies 2
• Don't use different enzyme doses unnecessarily - studies show no difference in response between high and low dose supplementation 5
• Don't overlook the hypoglycemia component - it requires separate pharmacologic management with acarbose, not just enzyme replacement

The evidence strongly supports that your patient with documented low disaccharidase activity will likely benefit from enzyme supplementation, with an 80% probability of symptomatic improvement. The reactive hypoglycemia component should be managed concurrently with acarbose for comprehensive symptom control.